Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 16914027)

1.

Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.

Saebø M, Skjelbred CF, Nexø BA, Wallin H, Hansteen IL, Vogel U, Kure EH.

BMC Cancer. 2006 Aug 16;6:208.

2.

High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.

Andersen V, Vogel LK, Kopp TI, Sæbø M, Nonboe AW, Hamfjord J, Kure EH, Vogel U.

PLoS One. 2015 Mar 20;10(3):e0119255. doi: 10.1371/journal.pone.0119255. eCollection 2015.

3.

PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1.

Dziaman T, Ludwiczak H, Ciesla JM, Banaszkiewicz Z, Winczura A, Chmielarczyk M, Wisniewska E, Marszalek A, Tudek B, Olinski R.

PLoS One. 2014 Dec 19;9(12):e115558. doi: 10.1371/journal.pone.0115558. eCollection 2014.

4.

Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.

Liu AY, Liu DG, Du YJ, Pei FH, Yang G, Liu BR, Zhang HT, Wang XH, Fan YJ, Chen YZ, Jiang Y, Chen J.

Cancer Biol Ther. 2014 May;15(5):489-95. doi: 10.4161/cbt.28016. Epub 2014 Feb 12.

5.

Low ABCB1 gene expression is an early event in colorectal carcinogenesis.

Andersen V, Vogel U, Godiksen S, Frenzel FB, Sæbø M, Hamfjord J, Kure E, Vogel LK.

PLoS One. 2013 Aug 19;8(8):e72119. doi: 10.1371/journal.pone.0072119. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/7cd6c6a6-b281-4bf3-b478-a289ed39b375.

6.

Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.

Smith CG, West H, Harris R, Idziaszczyk S, Maughan TS, Kaplan R, Richman S, Quirke P, Seymour M, Moskvina V, Steinke V, Propping P, Hes FJ, Wijnen J, Cheadle JP.

J Natl Cancer Inst. 2013 Aug 21;105(16):1249-53. doi: 10.1093/jnci/djt183. Epub 2013 Jul 12.

7.

Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescence.

Wong JC, Hasan MR, Rahman M, Yu AC, Chan SK, Schaeffer DF, Kennecke HF, Lim HJ, Owen D, Tai IT.

Int J Cancer. 2013 Oct 1;133(7):1567-77. doi: 10.1002/ijc.28180. Epub 2013 Apr 30.

PMID:
23536448
8.

Association of plasma endotoxin, inflammatory cytokines and risk of colorectal adenomas.

Kang M, Edmundson P, Araujo-Perez F, McCoy AN, Galanko J, Keku TO.

BMC Cancer. 2013 Feb 26;13:91. doi: 10.1186/1471-2407-13-91.

9.

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Meijer GA, Fijneman RJ.

Cell Oncol (Dordr). 2012 Aug;35(4):293-300. doi: 10.1007/s13402-012-0088-2. Epub 2012 Jun 19.

PMID:
22711543
10.

BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Fijneman RJ, Meijer GA.

J Pathol. 2012 Feb;226(3):442-50. doi: 10.1002/path.2983. Epub 2011 Oct 18.

PMID:
22009326
11.

DNA-ploidy analysis within selected regions of colorectal adenomas containing carcinoma.

Risio M, Geido E, Divinci A, Rapallo A, Pujic N, Rossini F, Giaretti W.

Int J Oncol. 1993 Nov;3(5):941-7.

PMID:
21573457
12.

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.

Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK.

BMC Cancer. 2011 Feb 10;11:65. doi: 10.1186/1471-2407-11-65.

13.

The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.

Avoranta T, Sundström J, Korkeila E, Syrjänen K, Pyrhönen S, Laine J.

Virchows Arch. 2010 Dec;457(6):659-67. doi: 10.1007/s00428-010-0992-7. Epub 2010 Oct 12.

PMID:
20938784
14.

Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients.

Obtulowicz T, Swoboda M, Speina E, Gackowski D, Rozalski R, Siomek A, Janik J, Janowska B, Ciesla JM, Jawien A, Banaszkiewicz Z, Guz J, Dziaman T, Szpila A, Olinski R, Tudek B.

Mutagenesis. 2010 Sep;25(5):463-71. doi: 10.1093/mutage/geq028. Epub 2010 Jun 9.

15.

Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk.

Hamilton KE, Lund PK, Galanko JA, Sandler RS, Keku TO.

BMC Res Notes. 2010 May 25;3:144. doi: 10.1186/1756-0500-3-144.

16.

Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.

Kopp R, Fichter M, Schalhorn G, Danescu J, Classen S.

Int J Mol Med. 2009 Nov;24(5):677-83.

PMID:
19787202
17.

[Expression of cyclooxygenase-2 and relationship with mismatch repair gene and microsatellite instability in hereditary non-polyposis colorectal cancer].

Zhang YH, Sheng JQ, Geng HG, Han M, Huang JS, Mu H, Han WL, Chen JG, Niu HL, Li AQ, Wu ZT, Li SR.

Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1377-81. Chinese.

PMID:
19671325
18.
19.

[Expression of AIF and caspase-3 in colorectal carcinoma, adenoma, and normal mucosa and its correlation].

Guan JT, Wang L, Wang Y, Li Y, Wang R, Zhang WY, Zhan L, Zhou ZG.

Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Jul;12(4):391-4. Chinese.

PMID:
19598027
20.

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, Kure EH, Vogel U, Vogel LK.

BMC Cancer. 2009 Jun 25;9:201. doi: 10.1186/1471-2407-9-201.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk